Investing

Morning Movers (LIVE, CTIC, ADGE, CSKI, BONE)

There are several stocks trading more heavily than usual this morning, and also experiencing large gains or drops in share prices. These include LiveDeal Inc. (NASDAQ: LIVE), Cell Therapeutics Inc. (NASDAQ: CTIC), American DG Energy Inc. (NASDAQ: ADGE), China Sky One Medical Inc. (NASDAQ: CSKI), and Bacterin International Holdings Inc. (NASDAQ: BONE).

After the 45 minutes of trading this morning, LiveDeal is up nearly 23% at $3.76. Volume is already nearly equal to the daily average. The customer acquisition company regained its compliance with Nasdaq listing requirements.

American DG Energy is up about 4% at $1.60. Volume is already higher than the daily average. The energy systems maker has signed a 15-year energy supply agreement with a 225-unit high-rise in New Jersey.

China Sky One Medical is down nearly -19% at $0.92, after posting a new 52-week low of $0.89 earlier. Volume is already more than double the daily average. The nutritional supplement maker’s CFO resigned, following the CEO’s decision last week to take a medical leave.

Bacterin is up about 4% at $2.60. Volume has nearly reached the daily average. The medical device maker’s stock is down -46% for the year and today’s increase likely indicates some value hunting on the part of investors.

Paul Ausick

Travel Cards Are Getting Too Good To Ignore

Credit card companies are pulling out all the stops, with the issuers are offering insane travel rewards and perks.

We’re talking huge sign-up bonuses, points on every purchase, and benefits like lounge access, travel credits, and free hotel nights. For travelers, these rewards can add up to thousands of dollars in flights, upgrades, and luxury experiences every year.

It’s like getting paid to travel — and it’s available to qualified borrowers who know where to look.

We’ve rounded up some of the best travel credit cards on the market. Click here to see the list. Don’t miss these offers — they won’t be this good forever.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.